FR2122529A1 - Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity - Google Patents

Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity

Info

Publication number
FR2122529A1
FR2122529A1 FR7201789A FR7201789A FR2122529A1 FR 2122529 A1 FR2122529 A1 FR 2122529A1 FR 7201789 A FR7201789 A FR 7201789A FR 7201789 A FR7201789 A FR 7201789A FR 2122529 A1 FR2122529 A1 FR 2122529A1
Authority
FR
France
Prior art keywords
cpds
peptide
delayed
biological activity
protein complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7201789A
Other languages
English (en)
French (fr)
Other versions
FR2122529B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt, Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Nyrt
Publication of FR2122529A1 publication Critical patent/FR2122529A1/fr
Application granted granted Critical
Publication of FR2122529B1 publication Critical patent/FR2122529B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
FR7201789A 1971-01-20 1972-01-19 Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity Granted FR2122529A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (2)

Publication Number Publication Date
FR2122529A1 true FR2122529A1 (en) 1972-09-01
FR2122529B1 FR2122529B1 (OSRAM) 1975-12-26

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7201789A Granted FR2122529A1 (en) 1971-01-20 1972-01-19 Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity

Country Status (10)

Country Link
AU (1) AU3784072A (OSRAM)
BE (1) BE778239A (OSRAM)
CA (1) CA972288A (OSRAM)
DD (1) DD98915A5 (OSRAM)
DE (1) DE2202176A1 (OSRAM)
ES (1) ES399033A1 (OSRAM)
FR (1) FR2122529A1 (OSRAM)
IL (1) IL38546A0 (OSRAM)
NL (1) NL7200716A (OSRAM)
ZA (1) ZA72252B (OSRAM)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202678A1 (OSRAM) * 1972-10-12 1974-05-10 Takeda Chemical Industries Ltd
FR2395026A1 (fr) * 1977-03-30 1979-01-19 Benzon As Alfred Dose medicamenteuse a unites multiples
EP0101027A1 (de) * 1982-08-18 1984-02-22 Herbert Prof. Dr. Rupprecht An Siliciumdioxid als Träger gebundene Wirkstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0189107A3 (de) * 1985-01-23 1987-09-02 Dieter Aderhold Therapeutisches, peptid- und/oder aminosäurehaltiges Mittel
EP0398619A3 (en) * 1989-05-16 1991-04-03 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758A1 (fr) * 1999-10-15 2001-04-20 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202678A1 (OSRAM) * 1972-10-12 1974-05-10 Takeda Chemical Industries Ltd
FR2395026A1 (fr) * 1977-03-30 1979-01-19 Benzon As Alfred Dose medicamenteuse a unites multiples
EP0101027A1 (de) * 1982-08-18 1984-02-22 Herbert Prof. Dr. Rupprecht An Siliciumdioxid als Träger gebundene Wirkstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0189107A3 (de) * 1985-01-23 1987-09-02 Dieter Aderhold Therapeutisches, peptid- und/oder aminosäurehaltiges Mittel
EP0398619A3 (en) * 1989-05-16 1991-04-03 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758A1 (fr) * 1999-10-15 2001-04-20 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
EP1092728A3 (fr) * 1999-10-15 2001-12-05 Exsymol S.A.M. Complexe à base d'acide orthosilicique biologiquement assimilable, se présentant sous forme solide, stable et concentrée, et procédé de préparation
US6335457B1 (en) 1999-10-15 2002-01-01 Exsymol S.A.M. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex

Also Published As

Publication number Publication date
DE2202176A1 (de) 1972-08-03
ZA72252B (en) 1972-09-27
AU3784072A (en) 1973-07-19
NL7200716A (OSRAM) 1972-07-24
DD98915A5 (OSRAM) 1973-07-12
BE778239A (fr) 1972-05-16
FR2122529B1 (OSRAM) 1975-12-26
ES399033A1 (es) 1975-05-16
CA972288A (en) 1975-08-05
IL38546A0 (en) 1972-03-28

Similar Documents

Publication Publication Date Title
DK121788A (da) Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse
BG104828A (en) Fap alpha-specific antibody with improved pruducibility
DE3786649D1 (de) Pferde-gamma-interferon.
PT87138A (pt) Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
BR9405507A (pt) Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
ATE49233T1 (de) Vektoren zur transformation von hefe.
BR9406993A (pt) Microesferas de gases insolúveis encapsulados com proteína e sua preparação e uso como agentes de imagem ultrassônica
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
SE9101433D0 (sv) Recombinant dna sequence and its use
IL80451A0 (en) Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides
FR2122529A1 (en) Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity
ATE144535T1 (de) Plättchen blockierende peptide
CA1000690A (en) N-protected amino acids and peptides
BR0014740A (pt) Lantibiótico
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE269904T1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
NO881904D0 (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
RU95107705A (ru) Полипептид, рекомбинантный полинуклеотид, вакцина, применение вакцины
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.
ATE82754T1 (de) Sorbin und abgeleitete peptide, die die absorption durch die mucosa erhoehen.
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
SE401956B (sv) Anvendning av med protein eller peptid polystyrenlatex som diagnostiskt reagens

Legal Events

Date Code Title Description
ST Notification of lapse